Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2005
10/27/2005US20050238659 Vaccine and method of use
10/27/2005US20050238656 Recombinant vesiculoviruses and their uses
10/27/2005US20050238652 Human lung adenocarcinoma-related monoclonal antibody and antigen and immunaossay method which uses the same
10/27/2005US20050238651 Treatment of inflammatory bowel disease
10/27/2005US20050238650 Compositions and methods for the treatment of tumor of hematopoietic origin
10/27/2005US20050238649 Monomethylvaline compounds capable of conjugation to ligands
10/27/2005US20050238647 Therapeutic uses for MDC and MDC antagonists
10/27/2005US20050238644 Preventive and/or therapeutic agent for systemic lupus erythematosus comprising anti-lL-6 receptor antibody as an active ingredient
10/27/2005US20050238643 Modulation of lir function to treat rheumatoid arthritis
10/27/2005US20050238642 Modified bouganin proteins, cytotoxins and methods and uses thereof
10/27/2005US20050238639 Use of relaxin to increase arterial compliance
10/27/2005US20050238637 Vectors for molecule delivery to CD11b expressing cells
10/27/2005US20050238627 Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer
10/27/2005US20050238626 Antigen specific T cell therapy
10/27/2005US20050238620 Suppressing fibrosis in a mammal having a fibrosing disease by administering a Serum Amyloid P (SAP) protein; treatment of diseases such as scleroderma, pulmonary fibrosis and asthma
10/27/2005US20050238582 Administering a conjugate of a a cell and a light-generating moiety; and measuring photon emission through an opaque tissue of said mammalian subject from the light-generating moiety; used for tracking the progression of infection
10/27/2005CA2776927A1 Phosphorylcholine conjugates and corresponding antibodies
10/27/2005CA2564115A1 Vaccination against malignant melanoma using bcg and/or vaccinia
10/27/2005CA2563408A1 Annexin v for preventing atherothrombois and plaque rupture
10/27/2005CA2563371A1 Methods of manufacture and use of calcium phosphate particles containing allergens
10/27/2005CA2563341A1 Erbb antagonists for pain therapy
10/27/2005CA2563295A1 Antibodies to erythropoietin receptor and uses thereof
10/27/2005CA2563260A1 Methods of treating autoimmune and inflammatory diseases
10/27/2005CA2562932A1 Apparatus and method for transdermal delivery of influenza vaccine
10/27/2005CA2562892A1 Bob-1 specific t cells and methods to use
10/27/2005CA2562784A1 Fluorocarbon antigen delivery vectors and constructs
10/27/2005CA2561533A1 Anti-p-selectin antibodies
10/27/2005CA2561494A1 Diagnosis and treatment of myeloid and lymphoid cell cancers
10/27/2005CA2561364A1 Steroid sparing agents and methods of using same
10/27/2005CA2559870A1 Mass spectrometry of antibody conjugates
10/26/2005EP1589115A2 Polymorphisms of the human organic anion transporting polypeptide-C (OATP-C)
10/26/2005EP1589111A1 Recombinant hepatitis a virus antigens obtained in plant cells
10/26/2005EP1589109A2 VMP-like sequences of pathogenic borrelia
10/26/2005EP1589108A2 Methods and reagents for vaccination which generate a CD8 T cell immune response
10/26/2005EP1589107A1 Immunoglobulins devoid of light chains
10/26/2005EP1589099A1 Immortalized natural killer cell line
10/26/2005EP1589034A2 Rationally designed antibodies
10/26/2005EP1589030A1 Bob-1 specific T cells and methods to use
10/26/2005EP1588714A2 Adjuvant systems and vaccines
10/26/2005EP1588713A1 Production of human papillomavirus HBV-11 capsid protein L1 and virus-like particles
10/26/2005EP1588712A1 Modulators of regulatory proteins
10/26/2005EP1588162A2 Hsc70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease
10/26/2005EP1587910A2 Facls as modifiers of the rb pathway and methods of use
10/26/2005EP1587908A2 Cellular delivery and activation polypeptide-nucleic acid complexes
10/26/2005EP1587838A2 Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation
10/26/2005EP1587834A2 Uses of mammalian cytokine; related reagents
10/26/2005EP1587789A2 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
10/26/2005EP1587550A2 Methods and compositions for administering therapeutic and diagnostic agents
10/26/2005EP1587542A1 Use of anti-cd100 antibodies
10/26/2005EP1587541A2 Compositions and methods of tolerizing a primate to an antigen
10/26/2005EP1587538A1 Mucosal meningococcal vaccines
10/26/2005EP1587533A1 A hybrid vector system for use as a vaccine
10/26/2005EP1587525A2 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus
10/26/2005EP1587483A2 Methods for modulating an inflammatory response
10/26/2005EP1587478A2 Pharmaceutical composition
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1169059B1 Docetaxel in combination with rhumab her2 for the treatment of cancers
10/26/2005EP1151010B1 Human polyclonal antibodies from transgenic nonhuman animals
10/26/2005EP0988370B1 Electrospraying apparatus and method for introducing material into cells
10/26/2005EP0951289B1 Use of mycobacterium vaccae for treating chronic fatigue syndrome
10/26/2005EP0876150B1 Non-toxic mutants of pathogenic gram-negative bacteria
10/26/2005CN1688707A Tiacumicin production
10/26/2005CN1688692A Cell proliferation inhibitors containing anti-glypican 3 antibody
10/26/2005CN1688607A Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use
10/26/2005CN1688606A Novel immunogenic lipopeptides comprising T-helper and B-cell epitopes
10/26/2005CN1688605A Novel immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes
10/26/2005CN1688604A Recombinant anti-osteopontin antibody and use thereof
10/26/2005CN1688603A Treatment and prophylaxis with 4-1BB-binding agents
10/26/2005CN1688602A Novel MHC II associated peptides
10/26/2005CN1688576A Thiophene compounds
10/26/2005CN1688364A Use of murine genomic regions identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer
10/26/2005CN1688338A Method of humanizing immune system molecules
10/26/2005CN1688336A Mycoplasma gallisepticum formulation, its mycoplasma strain k5054 and its application
10/26/2005CN1688335A Continuous cell line for the production of vaccines
10/26/2005CN1688334A Improved bacterial outer membrane vesicles
10/26/2005CN1688333A 疫苗 Vaccine
10/26/2005CN1686543A MODS-MOF interversion treating medicine EPO antibody EPO receptor, manufacturing method and animal model
10/26/2005CN1686542A Ox colostrum active immune globulin micro capsule and its preparation method
10/26/2005CN1686541A Preparation method of human macrocell virus pp65 protein vaccine
10/26/2005CN1686540A Preparation of tetravalent wheel shaped virus inactivated vaccine and application
10/26/2005CN1686539A HPV polypeptide vaccine and its preparation method
10/26/2005CN1686538A Dendron shaped cell tumour vaccine for loading withered heat shock tumour cell, its preparation method and application
10/26/2005CN1224712C Vector
10/26/2005CN1224708C i (Neisseria meningitidis) antigens
10/26/2005CN1224705C Toxoplasmosis composite multi-position genes
10/26/2005CN1224704C Preparing method for recombinant chBJSTWO protein
10/26/2005CN1224422C Vaccines comprising interleukin-12 and herpes simplex viral antigen
10/25/2005US6958361 Drugs, vaccines
10/25/2005US6958238 Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof
10/25/2005US6958237 Highly infectious rubella virus DNA constructs and methods of production
10/25/2005US6958235 Recombinant protein containing a C-terminal fragment of plasmodium MSP-1
10/25/2005US6958219 adding a labeled antibody, which binds to the autoinducer having a homoserine lactone ring with an N-acyl side chain, to a lysine-containing protein, and detection of immunospecific binding; N-(3-oxododecanoyl)-L-homoserine lactone
10/25/2005US6958212 coupling of a pharmaceutically active compound to a polymer using a conjugate addition reaction, and the cross-linking of the polymer to form a biomaterial, in some embodiments using conjugate addition reactions; controlled release of drug
10/25/2005US6958158 Immune modulation device for use in animals
10/25/2005US6958151 Miniprotein ligands and other polypeptides and methods for making and using same
10/25/2005US6958060 Method for muscle delivery of drugs, nucleic acids and other compounds
10/25/2005CA2229045C Use of muteins of wild-type cytokines as immunogens
10/25/2005CA2198195C Container with freeze-dried vaccine components
10/25/2005CA2185470C Compositions and methods for vaccines comprising .alpha.-galactosyl epitopes
10/20/2005WO2005097997A1 Compositions and methods for inducing anti-tumor immunity
1 ... 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 ... 1823